Our findings in the BT238 GBM PDX are consistent with the molecular heterogeneity of GBM tumors, since we found a significant variation in APELA expression in BTICs derived from different regions of the same GBM tumor (BT238XY versus BT238Z). This evidence concerns the gene APELA and neoplasm.